The serine-threonine kinase, Akt, is involved in the survival signaling pathways in many cell systems. The present study examined phosphorylation of Akt at serine-473 and DNA fragmentation after traumatic brain injury (TBI) in mice. Immunohistochemistry showed phospho-Akt was decreased in the injured cortex 1 h after TBI, whereas it was temporally increased at 4 h in the perifocal damaged cortex. In the CA1 region of the hippocampus, phospho-Akt was increased after TBI. Western blot analysis showed that Akt was significantly decreased as early as 1 h after trauma; however, the phosphorylation was accelerated at 4 h. Double staining with phospho-Akt and phospho-BAD or phospho-GSK-3␤ revealed the colocalization of phospho-Akt and downstream elements. Double staining with phospho-Akt and terminal deoxynucleotidyl transferase-mediated uridine 5-triphosphate-biotin nick end-labeling showed different cellular distributions after TBI. The present study implicates Akt phosphorylation in the signaling pathways that are involved in cell survival after TBI.
INTRODUCTION
The serine-threonine kinase, Akt, which is also referred to as protein kinase B and RAC, is the cellular homologue of the viral oncogene v-Akt. This protein kinase plays a critical role in controlling the balance between survival and apoptosis (Burgering & Coffer, 1995; Franke et al., 1995 Franke et al., , 1997 . Akt is activated by insulin and various growth and survival factors and functions in a wortmannin-sensitive pathway involving phosphatidylinositol 3-kinase (PI3-kinase) (Burgering & Coffer, 1995; Franke et al., 1995) . Akt contains an amino-terminal pleckstrin homology domain, which binds phosphorylated lipids at the membrane in response to activation of PI3-kinases. Akt is activated by phospholipid binding and activation loop phosphorylation at threonine-308 by phosphatidylinositol (3,4,5)-trisphosphate-deinase 1 (Alessi et al., 1996) and also within the C-terminus at serine-473 by integrin-linked kinase (Delcommenne et al., 1998) . After phosphorylation, Akt promotes cell survival and prevents apoptosis by inactivating several targets, including BAD (Datta et al., 1997; del Peso et al., 1997) , glycogen synthase kinase-3 (GSK-3) (Cross et al., 1995; Srivastava & Pandey, 1998) , forkhead transcription factors (Brunet et al., 1999; Kops & Burgering, 1999 ), or caspase-9 (Cardone et al., 1998 . According to recent reports, phospho-Akt also appears to negatively regulate the mitogen-activated protein kinase/extracellular-signal-responsive kinase kinase/extracellular-signal-responsive kinase pathway, inactivating Raf at serine-259 (Rommel et al., 1999; Zimmermann & Moelling, 1999) .
Apoptotic cell death has been demonstrated after experimental traumatic brain injury (TBI) in several studies (Beer et al., 2000; Clark et al., 1997 Clark et al., , 2000 LaPlaca et al., 2001; Lewén et al., 2001b; Lu et al., 2000; Rink et al., 1995; Yakovlev et al., 1997) . So far, several apoptogenic elements have been identified after TBI. Caspase-3 is known as an apoptotic executioner because it directly activates DNase, which leads to DNA fragmentation and cell death (Enari et al., 1998) . After TBI, caspase-3 mRNA expression (Yakovlev et al., 1997) and caspase-3 protein (Clark et al., 2000) were Neurobiology of Disease 9, 294 -304 (2002) 
